U.S. Central Lab Market Size & Outlook, 2023-2030
U.S. central lab market, 2018-2030 (US$M)
Related Markets
U.S. central lab market highlights
- The U.S. central lab market generated a revenue of USD 1,249.4 million in 2023 and is expected to reach USD 1,777.8 million by 2030.
- The U.S. market is expected to grow at a CAGR of 5.2% from 2024 to 2030.
- In terms of segment, biomarker services was the largest revenue generating services in 2023.
- Genetic Services is the most lucrative services segment registering the fastest growth during the forecast period.
Central lab market data book summary
| Market revenue in 2023 | USD 1,249.4 million |
| Market revenue in 2030 | USD 1,777.8 million |
| Growth rate | 5.2% (CAGR from 2023 to 2030) |
| Largest segment | Biomarker services |
| Fastest growing segment | Genetic Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology/Histology, Specimen Management & Storage, Special Chemistry Services |
| Key market players worldwide | LabConnect, Eurofins Scientific SE, A. P. Moller Maersk A/S ADR, ACM Global, Cerba Research, Synevo Central Labs, Versiti, Cenetron, Ampersand Capital Partners, Pacific Biomarkers, Cirion |
Other key industry trends
- In terms of revenue, U.S. accounted for 38.0% of the global central lab market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. central lab market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 171.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Central Lab Market Scope
Central Lab Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. central lab market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to central lab market will help companies and investors design strategic landscapes.
Biomarker services was the largest segment with a revenue share of 38.38% in 2023. Horizon Databook has segmented the U.S. central lab market based on genetic services, biomarker services, microbiology services, anatomic pathology/histology, specimen management & storage, special chemistry services covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. central lab market is anticipated to witness lucrative growth due to local presence of leading players, such as Cenetron and Pacific Biometrics. Presence of well-established infrastructure and favorable reimbursement policies are contributing to the market growth.
Furthermore, according to American Cancer Society, in 2021, around 1,898,160 new cases of cancer were reported in the U.S., and this number is projected to grow and reach 1,918,030 in 2022. These factors are expected to contribute to the market growth in the U.S.
Furthermore, dominance of the U.S. market is supported by significant percentage of clinical studies conducted in the country. According to clinicaltrials.gov, a total of 417,380 studies have been registered on the website, as of 5t h June 2022. Of these, about 32% of studies are being conducted in the U.S.
Reasons to subscribe to U.S. central lab market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. central lab market databook
-
Our clientele includes a mix of central lab market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. central lab market , including forecasts for subscribers. This country databook contains high-level insights into U.S. central lab market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. central lab market size, by services, 2018-2030 (US$M)
U.S. Central Lab Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
